DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Navari RM, Mosier MC.
Crossover safety study of aprepitant: 2-min injection vs 30-min infusion in cancer patients receiving emetogenic chemotherapy.
OncoTargets Ther 2019;
12: 3277-3284
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.